pGluc2-Nter-ERI1-R105A vector (V015438)

Basic Vector Information

Vector Name:
pGluc2-Nter-ERI1-R105A
Antibiotic Resistance:
Ampicillin
Length:
6861 bp
Type:
Cloning vector
Replication origin:
ori
Source/Author:
Declercq M, Biquand E, Karim M, Pietrosemoli N
Promoter:
CMV

pGluc2-Nter-ERI1-R105A vector Map

pGluc2-Nter-ERI1-R105A6861 bp3006009001200150018002100240027003000330036003900420045004800510054005700600063006600CMV enhancerCMV promoterchimeric intronsequencing primerT7 promoterGaussia luciferase domain 2attB13'-5' exoribonuclease 1attB2SV40 poly(A) signalsequencing primerf1 oriSV40 promoterNeoR/KanRpoly(A) signalAmpR promoterAmpRori

pGluc2-Nter-ERI1-R105A vector Sequence

LOCUS       V015438                 6861 bp    DNA     circular SYN 28-OCT-2020
DEFINITION  Exported.
ACCESSION   V015438
VERSION     V015438
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 6861)
  AUTHORS   Declercq M, Biquand E, Karim M, Pietrosemoli N, Jacob Y, Demeret C,
            Barbezange C, van der Werf S.
  TITLE     Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to
            promote viral transcription
  JOURNAL   Nucleic Acids Res 48 (18), 10428-10440 (2020)
   PUBMED   32960265
REFERENCE   2  (bases 1 to 6861)
  AUTHORS   Declercq M, Biquand E, Demeret C, Karim M, Pietrosemoli N, Jacob Y,
            Demeret C, Van der Werf S, Barbezange C.
  TITLE     Direct Submission
  JOURNAL   Submitted (03-SEP-2020) National Influenza Centre, Sciensano, Rue
            Juliette Wytsman 14, Brussels 1180, Belgium
REFERENCE   3  (bases 1 to 6861)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     ##Assembly-Data-START##
            Sequencing Technology :: Sanger dideoxy sequencing
            ##Assembly-Data-END##
            SGRef: number: 1; type: "Journal Article"; journalName: "Nucleic
            Acids Res"; date: "2020"; volume: "48"; issue: "18"; pages:
            "10428-10440"
            SGRef: number: 2; type: "Journal Article"; journalName: "Submitted
            (03-SEP-2020) National Influenza Centre, Sciensano, Rue Juliette
            Wytsman 14, Brussels 1180, Belgium"
FEATURES             Location/Qualifiers
     source          1..6861
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     enhancer        139..517
                     /label="CMV enhancer"
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        518..729
                     /label="CMV promoter"
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     intron          890..1022
                     /label="chimeric intron"
                     /note="chimera between introns from human beta-globin and
                     immunoglobulin heavy chain genes"
     misc_feature    1045..1060
                     /label="sequencing primer"
                     /note="sequencing primer"
     promoter        1067..1085
                     /label="T7 promoter"
                     /note="promoter for bacteriophage T7 RNA polymerase"
     misc_feature    1120..1389
                     /label="Gaussia luciferase domain 2"
                     /note="Gaussia luciferase domain 2"
     misc_feature    1278..1298
                     /label="sequencing primer"
                     /note="sequencing primer"
     protein_bind    1393..1417
                     /label="attB1"
                     /note="recombination site for the Gateway(R) BP reaction"
     CDS             1420..2466
                     /gene="ERI1"
                     /label="3'-5' exoribonuclease 1"
                     /note="3'-5' exoribonuclease 1 from Homo sapiens.
                     Accession#: Q8IV48"
     protein_bind    complement(2471..2495)
                     /label="attB2"
                     /note="recombination site for the Gateway(R) BP reaction"
     polyA_signal    complement(2547..2668)
                     /label="SV40 poly(A) signal"
                     /note="SV40 polyadenylation signal"
     misc_feature    complement(2785..2853)
                     /label="sequencing primer"
                     /note="sequencing primer"
     rep_origin      2854..3309
                     /label="f1 ori"
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"
     promoter        3428..3785
                     /label="SV40 promoter"
                     /note="SV40 enhancer and early promoter"
     CDS             3836..4627
                     /label="NeoR/KanR"
                     /note="aminoglycoside phosphotransferase"
     polyA_signal    4694..4742
                     /label="poly(A) signal"
                     /note="synthetic polyadenylation signal"
     promoter        5064..5168
                     /label="AmpR promoter"
     CDS             5169..6026
                     /label="AmpR"
                     /note="beta-lactamase"
     rep_origin      6200..6788
                     /direction=RIGHT
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"

This page is informational only.